Antipsychotic drug use in pregnancy: A multinational study from ten countries

Johan Reutfors(Karolinska Institutet), Gabriella Bröms(Danderyds sjukhus), Andrea L. Schaffer, Krista F. Huybrechts(Brigham and Women's Hospital), Kenneth K. C. Man(University College London Hospitals NHS Foundation Trust), Yongfu Yu(Fudan University), Tania Schink(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Brian T. Bateman(Stanford Medicine), Mika Gissler(Finnish Institute for Health and Welfare), Kari Furu(Norwegian Institute of Public Health), Alys Havard(UNSW Sydney), Kristjana Einarsdóttir(University of Iceland), Jacqueline M. Cohen(Norwegian Institute of Public Health), Laura Pazzagli(Karolinska Institutet), Maarit K. Leinonen(University of Helsinki), Carolyn E. Cesta(Karolinska Institutet), Ruth Brauer(University of London), Helga Zoëga(University of Iceland), Øystein Karlstad(Norwegian Institute of Public Health), Anders Engeland(Norwegian Institute of Public Health), Sonia Hernández–Dı́az(Harvard University), Jiong Li(Unknown), Zixuan Wang(University College London)
Schizophrenia Research
April 12, 2020
Cited by 54


Related Papers